
Apheon Bioscience
Rensselaer, NY, United States apheonbio.com From their website, Nov 2026
Work here? Claim this listing
About
Apheon Bioscience is a preclinical biotech in Rensselaer, New York that develops first-in-class immunotherapies and offers molecular biology services. It serves pharmaceutical partners, biotechnology companies, and research institutions in areas including women’s health, antibody engineering, immunotherapy, and DNA cloning.
Services
Immunotherapy development & target identification
Profiles disease states based on antigenicity, identifies biomarkers, generates biologic leads, and uses the ApheGenixID™ platform to discover tumor-associated antigens and therapeutic candidates.
Recombinant antibody development
Develops high-affinity recombinant antibodies using AI-assisted design, high-diversity library screening, hybridoma rescue, recombinant conversion, and humanization.
AI-assisted recombinant antibody design
Designs antibodies in silico against user-defined epitopes and delivers expression-ready clones.
High-diversity antibody library screening
Screens diverse antibody libraries using a proprietary display platform and delivers sequence-defined recombinant leads.
Hybridoma rescue & recombinant conversion
Sequences antibodies from hybridomas and transfers them into an optimized recombinant platform.
Precision antibody humanization
Uses CDR-grafting and framework selection to humanize antibodies while retaining binding properties.
DNA cloning
Provides custom plasmid cloning and sequence-verified plasmids using onboarded vectors.
PCR sub-cloning
Offers standard PCR subcloning into a customer-provided onboarded vector.
Minimum $200.00
4 more services
- Plasmid DNA purification
- Precision Cloning
- Disease Profiling / Immunotherapy Development
- ApheGenixID™ Antigen Discovery
- What to send
- Template DNA and onboarded vector for PCR sub-cloning
- E. coli strain with plasmid DNA or an aliquot of purified plasmid for plasmid DNA purification
- Customer-provided vector for custom cloning
- Minimums and prices
- PCR Sub-cloning $200.00
- pLasmid DNA Purification $100.00 – $250.00
Capabilities
- Assays and studies
- Antibodies
- Hybridoma
- Antigen discovery
- Target identification
- Binding analysis
- Library screening
9 more
- Hybridoma sequencing
- CDR-grafting
- Framework selection
- Antigenicity profiling
- Biomarker identification
- High-diversity library screening
- Hybridoma rescue
- AI-driven design
- Sequence refinement
- Scale and capacity
- Giga (> 3.0 mg plasmid DNA)
- Maxi (> 1.0 mg plasmid DNA)
- Midi (> 200 micrograms plasmid DNA)
- Basic: 2000 AI-designed candidates → 8 highest-probability leads cloned
- Standard: 5000 AI-designed candidates → 16 highest-probability leads cloned
- Premium: 10000 AI-designed candidates → 24 highest-probability leads cloned
- Therapeutic areas
- Women’s health
- Triple-Negative Breast Cancer
- TNBC
- Leiomyosarcoma
- Endometriosis
- Triple-Negative Breast Cancer (TNBC)
- Aggressive diseases
- Underserved conditions
Modalities and species
- Modalities
- Antibody
- Recombinant protein
- Plasmid DNA
- Species and models
- CHO
- E. coli
- Yeast
- Hybridoma
Industries served
- Biotechnology
- Pharmaceutical
- Academic research
- Synthetic biology
- Women’s health
Details
- Quality
- BIOSECURE Act Compliance (All cloning and data handling are conducted exclusively in the U.S.) · sequence-verified (Plasmids are delivered sequence-verified)
- Address
- 7 University Pl, Rm B130. Rensselaer, NY 12144
- Serves
- United States, global partners